Replies to post #122184 on Amarantus Bioscience Holdings Inc (AMBS)

[christjamin]

You may be right..I don't know. I am not for selling eltoprazine. I would rather JV on ESS for fund, take it to maturity then fund eltoprazine and Manf instead.

[SidVicious]

The financial uncertainty and mismanagement of Amarantus makes it difficult for any reputable and thriving pharma company, other than another struggling biotech like AVXL and AVDX, to partner. Why take the risk? Amarantus has to secure their financial future before we see any significant deal. And I will be shocked if we see any deal with ESS until positive results are seen. The only bright thing that could turn the fortunes around for the company is getting that special voucher for ESS that the company can then turn around and sell for a few hundred million dollars.